ESC 365 - Impact of baseline characteristics on efficacy of cilostazol for patients performing endovascular therapy for femoropopliteal lesions

ESC Premium Access

Impact of baseline characteristics on efficacy of cilostazol for patients performing endovascular therapy for femoropopliteal lesions

Session: Poster Session 4 - Peripheral artery disease : endovascular treatment

Topic: Intervention

Speaker: Doctor S. Hiramori (Kitakyushu, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Seiichi Hiramori

Kokura Memorial Hospital, Kitakyushu (Japan)

0 follower

9 more presentations in this session

Outcome of spot versus full-coverage nitinol stenting after endovascular therapy for femoropopliteal artery disease

Speaker: Doctor Y. Tomoi (Kitakyushu, JP)

Clopidorel-based antiplatelet therapy is not enough for stent patency in patients undergoing femoropopliteal arterial endovascular interventions.

Speaker: Doctor K. Higashi (Kagoshima, JP)

Long term usefulness of target lesion revascularization for asymptomatic restenosis of superficial femoral artery after endovascular therapy

Speaker: Doctor M. Utsunomiya (Tokyo, JP)

Comparison of transradial vs transfemoral access for iliac, femoral, and popliteal interventions. A single-center experience

Speaker: Associate Professor Z. Ruzsa (Szeged, HU)

Predictive value of vessel size for the long-term patency following self-expanding nitinol stent implantation in the superficial femoral artery

Speaker: Doctor K. Miki (Nishinomiya, JP)

Access the full session

Poster Session 4 - Peripheral artery disease : endovascular treatment

Speakers: Doctor S. Hiramori, Doctor Y. Tomoi, Doctor K. Higashi, Doctor M. Utsunomiya, Associate Professor Z. Ruzsa...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources